Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation.

N

NEJM

@NEJM · X

Visual Abstract: Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation

M病

MAX@病院薬剤師

@pharmax9 · X

【定期】アピキサバン2.5mg1日1回にするくらいなら、エドキサバン15mg1日1回にしろって言ってるんだよォ！ ※高齢、心房細動の方の話 https://t.co/eNsD9b415P

PG

Prof Dhiraj Gupta

@DhirajGuptaBHRS · X

Practice changing study @NEJM In elderly AF pts with contraindications to OAC, Edoxaban 15mg reduces composite of stroke/SE/ mortality with no addl risk of ICH Higher risk of GI bleed https://t.co/Io1HZrthrB https://t.co/XcFro8q1G1 https://t.co/SHDqswmcqY

だ腎

だるべ（腎臓内科）

@Darbepoeti_n · X

「超高齢者に抗凝固療法を行うべきか」については不明な点が多い。この研究で、低用量エドキサバン（15mg）は ✓80歳以上の日本人 ✓出血を増やさずに、脳梗塞を予防する ことがわかった。添付文章では許されていませんが、僕は高齢者にこの容量で処方することがあります https://t.co/PqmL5NJUqt https://t.co/sGwYhoNMHw

CT

Caio de Assis Moura Tavares

@caiodeamtavares · X

1/15 Since the publication of the ELDERCARE-AF in NEJM (https://t.co/bJtTZkPksc), I have seen a lot of residents and colleagues talking that “low dose” anticoagulation is the solution for older frail patients at high bleeding risk. That an “intermediate” dose would be the best

DL

Derek Leong

@Derek_Leong_RPh · X

ELDERCARE-AF: In Pts >80 y.o. with non-valvular AF, CHADS2 >1, unable to take OAC at approved doses, edoxaban 15 mg/d ⬇️stroke/systemic embolism vs. placebo (ARR 4.4%/year). ⬆️Bleeding with edoxaban, esp. GI bleed (ARI 1.5%/year), CRNMB (ARI 5.6%/year). https://t.co/jpxIcayR6t https://t.co/QvuV3hOnjb

M

Mar家庭医

@gene_fam_aura · X

超高齢者のAFに対する低用量エドキサバン(リクシアナ)の有効性について ・80歳以上、CHADS2スコア2点以上、かつ標準的な抗凝固療法(ワルファリンや通常量DOAC)が不適切とされた非弁膜症性AF患者984例が対象 ・介入群ではエドキサバン15mg/dayを投与 https://t.co/VR7gbgZHA4

に

にゃんでもにゃ医

@lE9BrvyUwLLVZIE · X

@TT58852391 こちらの有名なリクシアナ15mgのRCTは平均年齢86歳のようでした

KP

kakugari_pharmacist

@kakugaripharma · X

今日のモヤり そば先生とも会議。 これを脳梗塞の二次予防として外挿してよい？ under dose案件？ https://t.co/wrPnOioekC

EM

Emily McDonald

@DrEmilyMcD · X

RT @itraslan: @DrEmilyMcD Not that I use Edox often, but the dosing flexibility studied in RCTs is really helpful for shared decision makin…

IR

Ismail Raslan

@itraslan · X

@DrEmilyMcD Not that I use Edox often, but the dosing flexibility studied in RCTs is really helpful for shared decision making can even push down to 15mg https://t.co/Ro6w1Y85rE

仮H

(仮称)hanzou1121

@hanzou1121 · X

@Ryu04196650Ryu 最近はその辺のアンテナ乏しいので僕も明確に答えれないのですが、低容量で質が高い予防効果を狙うとなるedoxabanが高位に上がってくる認識です。あとは総合的な選択をするしかないのでしょうね。あとは参考指標とて既報からNNHを自力で算出するしかないのかもです。 https://t.co/7cZt9xn7C2

に

にいやん

@niiyan51 · X

Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation https://t.co/DmgyixM5Xy

SR

Su(Matt)riptan

@Ambcare_pharmer · X

@michael22joseph @DHidlayVIR @EzraTeitelbaum Not a periop study, but recent study that gets at some of these questions is eldercare-af. Low dose doac vs placebo in patients generally considered not eligible for OAC. https://t.co/v0BqNBbJcm

横

横山暁子

@yokoakipp · X

RT @pharmax9: 【定期】アピキサバン2.5mg1日1回にするくらいなら、エドキサバン15mg1日1回にしろって言ってるんだよォ！ ※高齢、心房細動の方の話 https://t.co/eNsD9b415P

M病

MAX@病院薬剤師

@pharmax9 · X

【定期】アピキサバン2.5mg1日1回にするくらいなら、エドキサバン15mg1日1回にしろって言ってるんだよォ！ ※高齢、心房細動の方の話 https://t.co/eNsD9b415P

パ牡

パン焦がし薬剤師(やっちゃん)@牡丹山薬局

@yo_ishii_2021 · X

『⽇本⼈超⾼齢者における⼼房細動に対する低⽤量エドキサバンの有⽤性』 https://t.co/k07i5FpTto https://t.co/cmSYpWQqca

XΚ

Xenophon Costeas - Ξενοφών Κωστέας

@XCosteas · X

RT @DrJasonAndrade: @RhythmHelp @drraviele @DrMarthaGulati @guroledip @cpgale3 @LuigiDiBiaseMD @TJaredBunch @SeguraCardio @PrashSanders @SA…

LB

Luigi Di Biase

@LuigiDiBiaseMD · X

RT @DrJasonAndrade: @RhythmHelp @drraviele @DrMarthaGulati @guroledip @cpgale3 @LuigiDiBiaseMD @TJaredBunch @SeguraCardio @PrashSanders @SA…

JA

Jason Andrade

@DrJasonAndrade · X

@RhythmHelp @drraviele @DrMarthaGulati @guroledip @cpgale3 @LuigiDiBiaseMD @TJaredBunch @SeguraCardio @PrashSanders @SABOURETCardio @mmamas1973 @gonzaeperez @ShelleyZieroth @Dr_Santangeli @JonPicciniSr @GiuseppeGalati_ We have that with eldercare. Though that assumes 2.5 bud of Apixaban is similar to edoxaban 15 https://t.co/p0rALtn40l

色ガ

色々自粛中(ガラス細工の様な繊細なハートを持つ貴公子

@ECGEPSCADEVICE · X

RT @tororo__ph:

ダ

ダックス医

@DachsClinic · X

循環器メモ：超高齢者へのDOAC投与 結論：リクシアナ15は日本発のエビデンスあり ELDER-CARE AF試験はDOAC躊躇しがちな、80歳以上の患者にエドキサバンとプラセボを比較したもの。ワーファリンとの比較でなくプラセボとの比較なのが珍しい。 続 https://t.co/slhcLzxPfA

ひ

ひそくちん

@E_hisoku · X

RT @Yohei_Kanzawa: そしてECSが盛り上がってるんですね。 超高齢者のAF、少量エドキサバン(リクシアナ)vsプラセボ。 日本から！ #心房細動 #DOAC Low-Dose Edoxaban in Very Elderly Patients with Atr…

JG

Journal of the Indian Academy of Geriatrics

@JIAGOfficial · X

An interesting and relevant study population selection by the ELDERCARE-AF group Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation | NEJM https://t.co/fx9e0qQTLc

YF

Yousef Fazel

@YouseffazelMD · X

RT @muddasir_ayazMD: GI is often asked about resumption of anticoagulation as a binary (yes/no) We owe it to our patients to be aware of e…

MA

Muddasir Ayaz

@TheGastrologer · X

GI is often asked about resumption of anticoagulation as a binary (yes/no) We owe it to our patients to be aware of emerging data to make more nuanced recommendations Data like

と

ときヲ

@toki_wo_koe · X

the ELDERCARE-AF これ好きです。 ばあさん(享年95歳)はエドキサバン15mg飲んでました。 親父殿は、早々に筆頭著者に焼いてもらうべきでした。紹介状は持っていたのに... Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation | NEJM https://t.co/YOVw9fxfeK

ア

アルココ

@aruko_koko · X

https://t.co/KLSOJ6icZd

ち

ちゃおせん

@EzmkN1 · X

@mackey_yo 高齢者に対してきめ細かく抗凝固薬を調整できないかとの試みも平行して検討されています。 あ、ASA＋DOACは避けるべきです。同意です。しかし循環器疾患を合併している場合や高度症候性ICSの場合は本人と家族と相談して処方するしかないかと忸怩たる思いです https://t.co/BV877Cx4bS

Tね

Takuya Kishi @ねこ好き循環器内科医

@tkishi_cardiol · X

RT @taora_bokujun: この話と思います 論文開きながら視聴できるのはWebのよさかも #22JCS https://t.co/dlXMhyYbfJ

日情

日本循環器学会 情報広報部会

@JCIRC_IPR · X

RT @taora_bokujun: この話と思います 論文開きながら視聴できるのはWebのよさかも #22JCS https://t.co/dlXMhyYbfJ

柴

柴田啓佑　循環器内科

@taora_bokujun · X

この話と思います 論文開きながら視聴できるのはWebのよさかも #22JCS https://t.co/dlXMhyYbfJ

ガ総

ガラパゴス伊藤@総合診療医

@galapagos_ito · X

リクシアナ15mgで使えるようになって嬉しいけど、プラセボとの比較なんだな。 他のDOACが基本ワーファリンとの非劣勢だから戦っている相手が違うことは認識必要。リクシアナ15mgは飲まないよりはマシくらいの感じ。 https://t.co/9U7QVxuzka

あA

あずーる@Azule

@Anazuresky2 · X

RT @Fizz_DI: 80歳以上でCHADS2≧2のNVAFに対するエドキサバン15mg/日 vs プラセボ（n=984、日本） ・脳卒中or全身性塞栓症 2.3％/年 vs 6.7%/年　HR=0.34 [95%CI:0.19-0.61] ・大出血 3.3%/年 vs…

MU

medical user

@UserMedical · X

RT @Fizz_DI: 80歳以上でCHADS2≧2のNVAFに対するエドキサバン15mg/日 vs プラセボ（n=984、日本） ・脳卒中or全身性塞栓症 2.3％/年 vs 6.7%/年　HR=0.34 [95%CI:0.19-0.61] ・大出血 3.3%/年 vs…

TO

Tororo_ph@EP Univ. oshademic

@tororo__ph · X

RT @Fizz_DI: 80歳以上でCHADS2≧2のNVAFに対するエドキサバン15mg/日 vs プラセボ（n=984、日本） ・脳卒中or全身性塞栓症 2.3％/年 vs 6.7%/年　HR=0.34 [95%CI:0.19-0.61] ・大出血 3.3%/年 vs…

FY

Fizz-DI＠比較と使い分け-KOJIMA Yushi

@Fizz_DI · X

80歳以上でCHADS2≧2のNVAFに対するエドキサバン15mg/日 vs プラセボ（n=984、日本） ・脳卒中or全身性塞栓症 2.3％/年 vs 6.7%/年　HR=0.34 [95%CI:0.19-0.61] ・大出血 3.3%/年 vs 1.8%/年　HR=1.87 [95%CI:0.90-3.89] N Engl J Med.383(18):1735-45,(2020) PMID:32865374 https://t.co/7qNVepNNTF

D

DrVeins

@drgarcivenas · X

@caperubono @Fosfolamban Mira así publican los japoneses a los que si les interesa la ciencia y la salud de los pacientes. https://t.co/zIkShcDpEP

WB

Western GIM Bison

@BisonGIM · X

RT @rahimkachra: Top 5 papers at #RMIM21 via Dr M Prystajecky. 4/5: Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation @N…

RK

Rahim Kachra

@rahimkachra · X

Top 5 papers at #RMIM21 via Dr M Prystajecky. 4/5: Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation @NEJM @RockyMtnIM https://t.co/i6bcsFNcvE

P

pinacol

@pinacol · X

【S54-1】あとはエドキサバンの例の論文。https://t.co/PmA0d5beuI #jsphcs2021

と

ときヲ

@toki_wo_koe · X

エドキサバン15mgの承認が少し経ちますELDERCARE-AFって結構面白くて ①半分ぐらい抗血小板薬併用 ②これまでは渋々30mgを飲んでいたであろう患者群。 OAC単剤と＋SAPT群で層別化して欲しい。 Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation | NEJM https://t.co/nFFwj7kN05

T北

TOMO@北の薬屋®

@kitanokusuriya · X

memoとして貼っておく ELDERCARE-AF https://t.co/Hu4SugMwEV https://t.co/iTMyLfXkKi

鯵C

鯵ゼミ_Journal Club

@AJSR_since2005 · X

#026 Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation N Engl J Med 2020; 383:1735-1745

く

くに

@daipc0203 · X

RT @Fizz_DI: CHADS2スコア≧2、80歳以上の日本人高齢者に対するエドキサバン15mg/日の有効性と安全性。 （年間発生率） ・塞栓症の複合 2.3% vs 6.7%：HR=0.34 [95%CI:0.19-0.61] ・大出血 3.3% vs 1.8%：HR…

FY

Fizz-DI＠比較と使い分け-KOJIMA Yushi

@Fizz_DI · X

CHADS2スコア≧2、80歳以上の日本人高齢者に対するエドキサバン15mg/日の有効性と安全性。 （年間発生率） ・塞栓症の複合 2.3% vs 6.7%：HR=0.34 [95%CI:0.19-0.61] ・大出血 3.3% vs 1.8%：HR=1.87 [95%CI:0.90-3.89] N Engl J Med.383(18):1735-45,(2020) PMID:32865374 https://t.co/7qNVepvEFx

た

たけちゃん

@nitrotake · X

エドキサバンの15mg低用量の試験。 vsプラセボで、出血リスクHR1.87; 95％CI 0.90〜3.89; P = 0.09 リスクは上がらない可能性があるかもって感じ？ 第一三共のかな？ https://t.co/aM1oQ3gjes

青発

青島周一@【書籍】「生成AIと学ぶ医学論文の読み方・考え方」発売中！

@syuichiao89 · X

やはり何度読み返しても、センスよいCQの論文だよなぁ。https://t.co/a0YJwLnIFK 確かに、標準⽤量のDOACが使⽤できない⾼齢者に対する抗凝固療法は、これまで臨床上未解決な問題であったと言ってもよい

在

在野の臨床医

@LLL_physician · X

80歳以上の心房細動患者に、エドキサバン低用量投与すると、プラセボと比べて脳卒中および全身塞栓症の発症が少なく、大出血は多い傾向にある。Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation https://t.co/ARWTw8nOLy

ウ

ウハクリニックまで何年かかるのだろう

@keitan0628 · X

RT @Darbepoeti_n: 「超高齢者に抗凝固療法を行うべきか」については不明な点が多い。この研究で、低用量エドキサバン（15mg）は ✓80歳以上の日本人 ✓出血を増やさずに、脳梗塞を予防する ことがわかった。添付文章では許されていませんが、僕は高齢者にこの容量で…

M

movedoc

@movedoc · X

Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation https://t.co/GBjCXNFRlA

D猫

Dr.猫太郎

@Dr_mew_resident · X

RT @Yohei_Kanzawa: そしてECSが盛り上がってるんですね。 超高齢者のAF、少量エドキサバン(リクシアナ)vsプラセボ。 日本から！ #心房細動 #DOAC Low-Dose Edoxaban in Very Elderly Patients with Atr…

と

ときヲ

@toki_wo_koe · X

大往生した祖母を偲んで思い出した試験。婆さん、15mg飲んでてやっぱよかったペーぞ！！元気でな〜(あの世で) ELDERCARE-AF 試験 Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation　 The New England Journal of Medicine（日本国内版） https://t.co/2vvWezcsZi

MD

Metabolic Health Digest

@methealthdigest · X

Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation Read more: https://t.co/FsbmD6385L #metabolicsyndrome #metabolichealthdigest #hypertension #hypertensionawerness #highbloodpressure #highbloodpressureproblems https://t.co/wPDTV6nxIJ

TL

Tiphaine Lenfant

@TiphaineLft · X

3) Edoxaban chez les patients > 80 ans en FA non valvulaire

G

GeriMedJC

@GeriMedJC · X

Next up on #GeriMedJC, @NEJM Eldercare-AF Trial: Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation https://t.co/GBeehYPZAq

O

OlgaDunaeva

@DunyaOlga · X

RT @GeriMedJC: Tune into #GeriMedJC on Nov 27 at 08:00 AM ET via Zoom: https://t.co/10EKfkm5Cg Low-Dose Edoxaban in Very Elderly Patients w…

DG

dov gandell

@dellightd · X

RT @GeriMedJC: Tune into #GeriMedJC on Nov 27 at 08:00 AM ET via Zoom: https://t.co/10EKfkm5Cg Low-Dose Edoxaban in Very Elderly Patients w…

G

GeriMedJC

@GeriMedJC · X

Tune into #GeriMedJC on Nov 27 at 08:00 AM ET via Zoom: https://t.co/10EKfkm5Cg Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation. https://t.co/GBeehYPZAq

DH

David Henry

@davidhenrymd · X

Full-dose anticoagulation is often used in a fib patients, but carries a risk of bleeding. This study shows that lower dose anticoagulation w/ edoxaban could accomplish the same stroke/heart attack prevention & lower the risk of bleeding for elderly pts https://t.co/7S46Y8RSir https://t.co/ubDbSdIfK5

内

内田

@uchida_kawasaki · X

RT @hichachu: Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation 「超高齢心房細動患者における低用量エドキサバンの有効性と安全性の検討」 https://t.co/S44uTgt…

ニ

ニューロドクター乱夢

@hichachu · X

Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation 「超高齢心房細動患者における低用量エドキサバンの有効性と安全性の検討」 https://t.co/S44uTgtOBS

ニ

ニューロドクター乱夢

@hichachu · X

Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation https://t.co/fXEAu5lGsF

S

SWDK

@sA0mJBMAA4snqUf · X

Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation | NEJM https://t.co/valwi1p0sD

RP

Royal College of General Practitioners

@rcgp · X

Have you read our new Essential Knowledge Update Journal Watch? It offers the latest clinical knowledge on topics including heart failure with reduced ejection fraction and low-dose edoxaban in very elderly patients with atrial fibrillation: https://t.co/H9wer5OVOc https://t.co/BstHey1qY8

RC

Rodrigo Nunes Cal

@CalZole · X

RT @NEJM: Visual Abstract: Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation

だ腎

だるべ（腎臓内科）

@Darbepoeti_n · X

「超高齢者に抗凝固療法を行うべきか」については不明な点が多い。この研究で、低用量エドキサバン（15mg）は ✓80歳以上の日本人 ✓出血を増やさずに、脳梗塞を予防する ことがわかった。添付文章では許されていませんが、僕は高齢者にこの容量で処方することがあります https://t.co/PqmL5NJUqt https://t.co/sGwYhoNMHw

AM

Antonio Manteca

@amango30 · X

RT @RevistaMFSamfyc: Edoxaban a dosis bajas en pacientes muy mayores con fibrilación auricular https://t.co/FiPqi8Z4dp PMID 32865374

RM

Revista MFAndalucia

@RevistaMFSamfyc · X

Edoxaban a dosis bajas en pacientes muy mayores con fibrilación auricular https://t.co/FiPqi8Z4dp PMID 32865374

通

通りすがりの麻酔科医

@torisugari_anes · X

https://t.co/VdV041Jj7D 80歳以上の日本人の非弁膜症性afに対するエドキサバンの効果を調べたRCT 結果は脳梗塞or全身性塞栓症の発生率は、介入群で2.3%、対照群で6.7%だった(HR:0.34[0.19-0.61])出血発生率は実質的に介入群で多かった(3.3%vs1.8%;HR:1.87[0.90-3.89]) #当麻_凝固

H

Higinio

@curabellas · X

RT @NEJM: Visual Abstract: Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation

J

James

@James51650277 · X

RT @NEJM: Visual Abstract: Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation

EB

Eileen Burns

@EileenBurns13 · X

RT @YoungGeris: Great to see research in over 80s in the @NEJM , albeit with the outdated phrase 'elderly' in the title. https://t.co/vZZI…

MS

Moisés Sánchez

@sgmoise · X

Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation | NEJM https://t.co/hFBj5GaJLO

YI

Young Geris (irony intended)

@YoungGeris · X

Great to see research in over 80s in the @NEJM , albeit with the outdated phrase 'elderly' in the title. https://t.co/vZZI5ZijYS

KM

Kevin K. Chung, MD

@chungk1031 · X

Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation | NEJM https://t.co/g8eybBsgWb

CG

Carlos E. Goicochea

@Carlos_E_Goico · X

RT @NEJM: Visual Abstract: Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation

PP

Pankti Pandya

@pankti4299 · X

RT @NEJM: Visual Abstract: Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation

SJ

Salud juntos

@alfonso_casi · X

En japoneses ≥80 años con fibrilación auricular no valvular no candidatos a anticoagulantes orales, 15 mg de edoxabán/día fue superior al placebo en la prevención de ACVs o embolia sistémica, sin aumento significativo hemorragia mayor vs. placebo. https://t.co/yIT1iW9BFP

SB

Simone Biscaglia

@SimoneBiscaglia · X

RT @caiodeamtavares: 1/15 Since the publication of the ELDERCARE-AF in NEJM (https://t.co/bJtTZkPksc), I have seen a lot of residents and c…

R

Ricardo

@ricardoconsua · X

RT @NEJM: Visual Abstract: Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation

M

[{MAVERICK}]

@Moileon2019 · X

Okumura K, Akao M, Yoshida T, et al.; ELDERCARE-AF Committees and Investigators. Low-dose edoxaban in very elderly patients with atrial fibrillation. N Engl J Med. 2020; 383: 1735-45. #LowDose #Edoxaban #VeryElderlyJapanesePatients #NonValvularAtrialFibri…https://t.co/YMMYcYEtOV

AS

Alexandre Anderson de Sousa Munhoz Soares

@Alexandre_ASMS · X

RT @caiodeamtavares: 1/15 Since the publication of the ELDERCARE-AF in NEJM (https://t.co/bJtTZkPksc), I have seen a lot of residents and c…

EJ

Emer Jean

@EmerJean1 · X

5/5 Dans la fibrillation auriculaire du sujet âgé, l’edoxaban à faible dose est supérieur au placebo et ne provoque pas plus de saignement https://t.co/Aq4cACFzSQ

EV

ERICK J. VAZQUEZ

@MDErickvzqz · X

RT @NEJM: Visual Abstract: Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation

IH

Inspira Health

@InspiraHealth1 · X

RT @NEJM: Visual Abstract: Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation

CT

Caio de Assis Moura Tavares

@caiodeamtavares · X

1/15 Since the publication of the ELDERCARE-AF in NEJM (https://t.co/bJtTZkPksc), I have seen a lot of residents and colleagues talking that “low dose” anticoagulation is the solution for older frail patients at high bleeding risk. That an “intermediate” dose would be the best

FG

Felice Gragnano

@FeliceGragnano · X

RT @DhirajGuptaBHRS: Practice changing study @NEJM In elderly AF pts with contraindications to OAC, Edoxaban 15mg reduces composite of…

TB

Thomas Jared Bunch

@TJaredBunch · X

RT @DhirajGuptaBHRS: Practice changing study @NEJM In elderly AF pts with contraindications to OAC, Edoxaban 15mg reduces composite of…

TW

Tomos Walters

@fitzroytomos · X

RT @DhirajGuptaBHRS: Practice changing study @NEJM In elderly AF pts with contraindications to OAC, Edoxaban 15mg reduces composite of…

AB

Alex Bowles

@AlexB_Pharm · X

RT @NEJM: Visual Abstract: Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation

JP

Jack Pluenneke

@JackPluenneke · X

https://t.co/RwVimbUbXm

南P

南郷 栄秀／Eishu NANGO, MD, PhD

@enango · X

https://t.co/QeQFqQe9d0 https://t.co/7Ip36I8Wui

NC

Nash_Creative

@NashCreative1 · X

RT @NEJM: Visual Abstract: Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation

MS

Majo Suing

@Majis171 · X

RT @NEJM: Visual Abstract: Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation

KC

Kashif Chaudhry

@KashifMD · X

RT @NEJM: Visual Abstract: Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation

ER

Euri Rivas

@euri_rivas · X

RT @vic_pallares:

N

NeuroIR

@neuro_ir · X

RT @NEJM: Visual Abstract: Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation

TN

Trung Nguyen

@drtrungnguyen · X

RT @NEJM: Visual Abstract: Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation

CB

Carlos Boyzo

@CarlosBoyzo10 · X

RT @NEJM: Visual Abstract: Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation

ES

Electrophysiology Nurse Specialist

@g_arrhythmia · X

RT @DhirajGuptaBHRS: Practice changing study @NEJM In elderly AF pts with contraindications to OAC, Edoxaban 15mg reduces composite of…

IM

Ivan Mendoza

@mencardio · X

RT @vic_pallares:

E

EM2025

@em_em2025 · X

RT @NEJM: Visual Abstract: Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation

US

Umar Shakur

@u_shakur · X

RT @NEJM: Visual Abstract: Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation

MW

Michelle Wood

@Mwoodspain · X

RT @NEJM: Visual Abstract: Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation

DP

daniele.pastori

@daniele_pastori · X

RT @DhirajGuptaBHRS: Practice changing study @NEJM In elderly AF pts with contraindications to OAC, Edoxaban 15mg reduces composite of…

DM

Dr H. Mohamed

@moh_warbuffet · X

RT @NEJM: Visual Abstract: Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation

AF

Abel Torrelles Fortuny

@abel_torrelles · X

RT @NEJM: Visual Abstract: Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation

猫

猫になりたい薬剤師

@Vannyamoto · X

RT @NEJM: Visual Abstract: Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation

MA

Mr Anonymous

@WLancsGP · X

RT @NEJM: Visual Abstract: Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation

PS

Prash Sanders

@PrashSanders · X

RT @DhirajGuptaBHRS: Practice changing study @NEJM In elderly AF pts with contraindications to OAC, Edoxaban 15mg reduces composite of…

BK

Bil Kirmani

@drkirmani · X

RT @DhirajGuptaBHRS: Practice changing study @NEJM In elderly AF pts with contraindications to OAC, Edoxaban 15mg reduces composite of…

AA

AF Association

@AtrialFibUK · X

RT @DhirajGuptaBHRS: Practice changing study @NEJM In elderly AF pts with contraindications to OAC, Edoxaban 15mg reduces composite of…

LF

Lynsey Fielden

@lynseyfielden1 · X

RT @NEJM: Visual Abstract: Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation

FL

Frank Lindemann

@FrankLindemann3 · X

RT @NEJM: Visual Abstract: Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation

LS

Liverpool Centre for Cardiovascular Science

@LiverpoolCCS · X

RT @DhirajGuptaBHRS: Practice changing study @NEJM In elderly AF pts with contraindications to OAC, Edoxaban 15mg reduces composite of…

GW

Gray Wolf

@GreyWol27926578 · X

RT @NEJM: Visual Abstract: Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation

PG

Prof Dhiraj Gupta

@DhirajGuptaBHRS · X

Practice changing study @NEJM In elderly AF pts with contraindications to OAC, Edoxaban 15mg reduces composite of stroke/SE/ mortality with no addl risk of ICH Higher risk of GI bleed https://t.co/Io1HZrthrB https://t.co/XcFro8q1G1 https://t.co/SHDqswmcqY

MP

Marco Paladino

@m_pala96 · X

RT @NEJM: Visual Abstract: Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation

AC

Airiau Caroline

@caroairiau · X

RT @NEJM: Visual Abstract: Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation

PS

Peter Schellongowski

@Schellongowski · X

RT @NEJM: Visual Abstract: Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation

JL

Jose Daniel Mosquera Lozano

@jdmosqueral · X

RT @NEJM: Visual Abstract: Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation

RM

Rosa Martínez

@mtnez_rosa · X

RT @NEJM: Visual Abstract: Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation

DK

Dr Khalid

@rauf_khalid · X

RT @NEJM: Visual Abstract: Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation

G

Gabriela

@DraGabiCampos · X

RT @NEJM: Visual Abstract: Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation

P

PD⚕⚖️

@pamedr15 · X

RT @NEJM: Visual Abstract: Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation

L

lizzet

@lizzet_neftis · X

RT @NEJM: Visual Abstract: Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation

WA

Wafaa Bin Ali

@MsBinAli · X

RT @NEJM: Visual Abstract: Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation

KD

Kevin Daniel

@kevdaniel10 · X

RT @NEJM: Visual Abstract: Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation

KJ

Kyle James

@1kylejam · X

RT @NEJM: Visual Abstract: Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation

AM

Ali S. Raja, MD

@AliRaja_MD · X

RT @NEJM: Visual Abstract: Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation

PM

Pub Health Monitor

@monitor_PH · X

RT @NEJM: Visual Abstract: Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation

N

NEJM

@NEJM · X

Visual Abstract: Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation

I

@investigando

@rocatanho · X

En pac muy ancianos c/FA no valv no candidatos para dosis estándar de ACO, una dosis de 15 mg una vez al día de edoxaban sería superior a placebo previniendo el ictus o el embolismo sistémico y no resultaría en una mayor incidencia de sangrado mayor https://t.co/aLJJqTuIyJ

AD

Alan Dow

@alan_dow · X

A touch of Edox? In 80+ year olds with non-valvular Afib and at high-risk for anti-coagulation, half-dose Edoxaban cuts stroke risk by 2/3s with no change in mortality. Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation | NEJM https://t.co/NgZuHmS8Q4

US

Unya S

@UnyaS · X

RT @drjohnmorley: Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation | NEJM https://t.co/X1RPWG5vqg

JM

john morley

@drjohnmorley · X

Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation | NEJM https://t.co/X1RPWG5vqg

S

Shibley

@dr_shibley · X

RT @GiusepeBellelli: Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation | NEJM https://t.co/bxNmC8X9iE

GB

Giuseppe Bellelli

@GiusepeBellelli · X

Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation | NEJM https://t.co/bxNmC8X9iE

DV

Dr Jean Pierre Laroche #vacciné 6.0

@Echoraljpangio · X

Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation | NEJM https://t.co/W5QufGsG5Q

雪医

雪むかえー脳神経内科/医学英語

@YukimukaeMemo · X

【気になった論文】 NEJMより，80歳以上のNVAFに対するLow-Dose Edoxabanの二重盲検プラセボ比較試験．日本からの報告． いずれはNVAFに対するEdoxaban15mgも適応になるのだろうか… https://t.co/rP5pd7bDC6

H

HN

@nagano_1123 · X

CHADS2≧2で抗凝固薬の通常使用に不適切と考えられた80歳以上のAf患者をエドキサバン15mgとplaceboを比較した日本発のRCT. Stroke＋全身塞栓は2.3％ vs 6.7%（HR 0.34 CI 0.19-0.61)、major bleedingは3.3% vs 1.8%(HR 1.87 CI 0.90-3.89). https://t.co/WGcPWsplRP

EH

Ernesto Rodríguez H

@ernestocardio · X

Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation | NEJM https://t.co/yS2yfMcoHP

GZ

Giuseppe Biondi-Zoccai

@gbiondizoccai · X

"...In very elderly Japanese patients with NVAF who were not appropriate candidates for standard doses of OAC, a once-daily 15-mg dose of edoxaban was superior to placebo in preventing stroke or systemic embolism, without more major bleedings..." https://t.co/LwU1BUA5TQ https://t.co/Fi4vUYYRXl

AM

antonio ramon muñoz

@armunyoz · X

RT @rincondesisifo: (2 minute medicine) El edoxabán a dosis BAJAS previene los ACV en pac ancianos con FA https://t.co/rW3ibPHPa6 REC de E…

MS

Mohamed Shiha

@Mo_Shiha · X

RT @RichardPollok: Also consider low dose Edoxaban in elderly with AF https://t.co/hic1jdQjvX

PP

Prof Richard Pollok

@RichardPollok · X

Also consider low dose Edoxaban in elderly with AF https://t.co/hic1jdQjvX https://t.co/697tb7Q6U1

は

はぎ

@hagi220 · X

心房細動の非常に高齢の患者における低用量エドキサバン-PubMed https://t.co/AjRt7XuJnd https://t.co/Z3haS2WkSZ

P

pharmaciensAPES

@pharmaciensAPES · X

Étude japonaise de phase 3 concluant que l’edoxaban 15 mg par jour est >au placebo pour prévenir les incidents cardiovasculaires chez les 80 ans avec FA non-valvulaire, ayant des contre-indications aux doses usuelles d’anticoagulants en prévention de l’AVC https://t.co/dkABYUVpz8 https://t.co/V3xB8z5kX2

C

Carmelo

@carmelprzrz · X

RT @rincondesisifo: (2 minute medicine) El edoxabán a dosis BAJAS previene los ACV en pac ancianos con FA https://t.co/rW3ibPHPa6 REC de E…

OH

Omid Hakami Hakami

@Omidhakami · X

RT @rincondesisifo: (2 minute medicine) El edoxabán a dosis BAJAS previene los ACV en pac ancianos con FA https://t.co/rW3ibPHPa6 REC de E…

R

rincondesisifo

@rincondesisifo · X

(2 minute medicine) El edoxabán a dosis BAJAS previene los ACV en pac ancianos con FA https://t.co/rW3ibPHPa6 REC de ECA https://t.co/S63WGiITpl Estudio original https://t.co/sVvuhEqeGY

MA

Mohammed Abufarhaneh

@MAbufarhaneh · X

Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation | NEJM https://t.co/CdR7mXwbGa

RP

Roxana Flores A. MD,PhD

@flo_rox · X

RT @StrokeAHA_ASA: Chaos About Treatment of Chaotic Heartbeat in Elderly Patients https://t.co/A8NOcuoQuj In this blog post, #BloggingStrok…

SA

Stroke AHA/ASA

@StrokeAHA_ASA · X

Chaos About Treatment of Chaotic Heartbeat in Elderly Patients https://t.co/A8NOcuoQuj In this blog post, #BloggingStroke contributor Nurose Karim discusses @NEJM article "Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation" #stroke https://t.co/FJR6hvoAK0

RM

Rubina Malik

@rubinamalikmd · X

RT @MontefioreGeri: REMINDER: #Geriatrics fellows' #journalclub this afternoon at 2PM! See you there! DM for Zoom link. #GeriMed Low-Dose…

MG

Montefiore Geriatrics

@MontefioreGeri · X

REMINDER: #Geriatrics fellows' #journalclub this afternoon at 2PM! See you there! DM for Zoom link. #GeriMed Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation @NEJM https://t.co/OraqKmCAN4

OS

Oliver Segal

@DrOliverSegal · X

Once daily 15mg edoxaban superior to placebo in preventing stroke or systemic embolism in ELDERCARE-AF rial and incidence of major bleeding not significantly higher. https://t.co/b2kHj74fEq

AC

@aroonsirimd@med-mastodon.com

@AroonsiriMD · X

Do you have older nonvalvular Afib >=80YO who can't take standard dose AC? @NEJM Try Edoxaban 15mg/day. Less stroke, no⬆️major bleeding vs placebo @TempleIM @aliachisty @PaulNWilliamz @JMAllenbaugh @jaimefine @LaReinaJay10 https://t.co/hR0SEfIyuC https://t.co/VXxvX5xQ3h

C

co

@co48466745 · X

低用量エドキサバンのエビデンスって、これかな？ https://t.co/zD0dCzrnRo

PM

perfectly misaligned

@sksicsicsic · X

RT @NEJM: Original Article: Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation #ESCCongress

C

Cardiology

@PracUpCardio · X

Low-Dose Edoxaban in Very Elderly Patients With Atrial Fibrillation https://t.co/DI0s1k0vij #cardiology

O

OlgaDunaeva

@DunyaOlga · X

RT @Derek_Leong_RPh: ELDERCARE-AF: In Pts >80 y.o. with non-valvular AF, CHADS2 >1, unable to take OAC at approved doses, edoxaban 15 mg/d…

DB

Dr. bycomet

@bycomet · X

“Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation - PubMed” https://t.co/hnykOLe3lS

GF

Gord Fogg

@GordFogg · X

RT @Derek_Leong_RPh: ELDERCARE-AF: In Pts >80 y.o. with non-valvular AF, CHADS2 >1, unable to take OAC at approved doses, edoxaban 15 mg/d…

DM

Devon McDonald

@McDevonMD · X

RT @Derek_Leong_RPh: ELDERCARE-AF: In Pts >80 y.o. with non-valvular AF, CHADS2 >1, unable to take OAC at approved doses, edoxaban 15 mg/d…

DL

Derek Leong

@Derek_Leong_RPh · X

ELDERCARE-AF: In Pts >80 y.o. with non-valvular AF, CHADS2 >1, unable to take OAC at approved doses, edoxaban 15 mg/d ⬇️stroke/systemic embolism vs. placebo (ARR 4.4%/year). ⬆️Bleeding with edoxaban, esp. GI bleed (ARI 1.5%/year), CRNMB (ARI 5.6%/year). https://t.co/jpxIcayR6t https://t.co/QvuV3hOnjb

MB

Michael Buratovich

@MichaelBuratovi · X

Low-Dose Edoxaban in Very Elderly Patients With Atrial Fibrillation | comment: Peter Lin MD, CCFP https://t.co/IdzlpZn4sR via @practiceupdate

O

Oncology

@PracUpOnc · X

Low-Dose Edoxaban in Very Elderly Patients With Atrial Fibrillation https://t.co/GTEZh9nPvF #hematology

K

koureiigaku

@koureiigaku · X

結論として、標準量の経口抗凝固薬が適応外の日本の超高齢非弁膜症性心房細動患者に対するエドキサバン15mg/日投与は、偽薬よりも脳卒中もしくは全身性塞栓症の予防効果に優れ大出血を増やしませんでした。 https://t.co/soriuCqKqe

ER

Euri Rivas

@euri_rivas · X

RT @mencardio: Low-Dose Edoxaban in Very Elderly Patients With Atrial Fibrillation | comment: Peter Lin MD, CCFP https://t.co/Mx5y1drrhv vi…

IM

Ivan Mendoza

@mencardio · X

Low-Dose Edoxaban in Very Elderly Patients With Atrial Fibrillation | comment: Peter Lin MD, CCFP https://t.co/Mx5y1drrhv via @practiceupdate

K川

kawasakigim@川崎市立川崎病院総合内科

@kawasakigim · X

総合内科は毎日のアップデートを欠かしません！今日は研修医の先生とELDERCARE-AF試験を読みました。日本発の質の高いRCTです。https://t.co/TILPqOxvFX

O

onioni

@ONIONI_abc · X

Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation https://t.co/N6YmKbdYCv

EA

Eslam Abdellah

@EslamAbdellah8 · X

RT @ChaturvediNeuro: Getting clinicians to anticoagulate elderly patients with A FIB is challenging, esp. with previous falls/GI bleeds. EL…

の

のんびり

@ONQlrhPIX79SPoj · X

https://t.co/9Jx6AYiYJv

Y

yuhei

@yxip01 · X

RT @koureiigaku: 80歳以上の超高齢心房細動者に対する低用量のエドキサバンの有効性と安全性を評価したELDERCARE-AF試験の論文がNEJMに掲載されていたので抄訳します。 結果、エドキサバン15mg/日投与は偽薬より脳卒中や全身性塞栓症が少なく、大出血の発…

令

令和姥捨山病院窓際内科

@setrq9HfAVRwdju · X

Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation | NEJM https://t.co/83dI9Qs0ce

岩老

岩手医科大学 脳神経内科・老年科

@IwateNeurol · X

RT @koureiigaku: 80歳以上の超高齢心房細動者に対する低用量のエドキサバンの有効性と安全性を評価したELDERCARE-AF試験の論文がNEJMに掲載されていたので抄訳します。 結果、エドキサバン15mg/日投与は偽薬より脳卒中や全身性塞栓症が少なく、大出血の発…

แก

แมว(ไม่ว่างแล้ว)ในจักรวาล

@RaviponSH · X

Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation | NEJM https://t.co/anGYl2Qiho

K

koureiigaku

@koureiigaku · X

80歳以上の超高齢心房細動者に対する低用量のエドキサバンの有効性と安全性を評価したELDERCARE-AF試験の論文がNEJMに掲載されていたので抄訳します。 結果、エドキサバン15mg/日投与は偽薬より脳卒中や全身性塞栓症が少なく、大出血の発生も多くはありませんでした。 https://t.co/ERRfkQifDt

DA

Denis A

@Merckxcycling · X

RT @bryanacotton1: Lemme fix conclusion by showing results...”rate of major bleeding was 3.3% in edoxaban group, 1.8% in placebo (P=0.09)..…

BB

Behnood Bikdeli

@bbikdeli · X

RT @juanjolopezn: In very elderly patients with nonvalvular #AF who were not appropriate candidates for standard doses of oral anticoagulan…

MH

Mayra Hawkins

@mayrahawkinssh · X

RT @juanjolopezn: In very elderly patients with nonvalvular #AF who were not appropriate candidates for standard doses of oral anticoagulan…

青発

青島周一@【書籍】「生成AIと学ぶ医学論文の読み方・考え方」発売中！

@syuichiao89 · X

RT @syuichiao89: ［文献］心房細動を有する超高齢者に低用量エドキサバンで脳卒中及び全身性塞栓症が少ないかもしれない（RCT DOI: 10.1056/NEJMoa2012883） : 薬剤師の地域医療日誌 https://t.co/A5qFXEkb21

HB

Hilario Badiola

@hilariobad59 · X

RT @jsenior64: #ESCCongress #ESCCongress2020 @escardio siguió con el ELDERCARE AF, edoxaban en pacientes > 80 años con FA con resultados po…

青発

青島周一@【書籍】「生成AIと学ぶ医学論文の読み方・考え方」発売中！

@syuichiao89 · X

［文献］心房細動を有する超高齢者に低用量エドキサバンで脳卒中及び全身性塞栓症が少ないかもしれない（RCT DOI: 10.1056/NEJMoa2012883） : 薬剤師の地域医療日誌 https://t.co/A5qFXEkb21

AH

Ana Blanco Hidalgo

@anablancoha · X

RT @jsenior64: #ESCCongress #ESCCongress2020 @escardio siguió con el ELDERCARE AF, edoxaban en pacientes > 80 años con FA con resultados po…

TI

Tobenna Iyidobi

@Tobennaiyidobi · X

RT @NEJM: Original Article: Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation #ESCCongress

ES

EB Sladek

@eb_sladek · X

Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation | NEJM https://t.co/DmIb1ukl4z

は

はぎ

@hagi220 · X

RT @pinacol: 【RCT】脳卒中予防に承認された投与量での経口抗凝固薬治療が適切でないと考えられる高齢（≥80歳）の心房細動患者へのエドキサバン15mg/dayの投与は、プラセボと比較して、脳卒中/全身性塞栓症の年率を減少させ、大出血の年率に差はなかった（消化管出血は…

P

pinacol

@pinacol · X

【RCT】脳卒中予防に承認された投与量での経口抗凝固薬治療が適切でないと考えられる高齢（≥80歳）の心房細動患者へのエドキサバン15mg/dayの投与は、プラセボと比較して、脳卒中/全身性塞栓症の年率を減少させ、大出血の年率に差はなかった（消化管出血は多かった）。 #ペ読 https://t.co/PmA0d5beuI

GT

Gaurav Thakur

@GThakurBrainDO · X

RT @VivienHLee: ELDERARE-AF. In elderly Japanese pts with Afib not appropriate for standard AC, low-dose edoxaban (15mg QD) was superior to…

と

ときヲ

@toki_wo_koe · X

周回遅れ。これ結果出てたんですね、エドキバン15mg。驚くような内容ではないが、有意差の付いていないmajor bleedingは症例数の問題だろう考察される。 Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation | NEJM https://t.co/mtwHLyY32c

VF

Vivien Lee MD FAAN

@VivienHLee · X

ELDERARE-AF. In elderly Japanese pts with Afib not appropriate for standard AC, low-dose edoxaban (15mg QD) was superior to placebo in preventing #stroke or systemic embolism. Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation | NEJM https://t.co/qQ5xOVXbuN

JM

John Morley

@Meddocslu · X

Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation | NEJM https://t.co/rsXMhbWvEj

PC

Professor Hanne Christensen

@HanneKChr · X

RT @NINDSdirector: More evidence that anticoagulants reduce #stroke in persons with Atrial Fibrillation; even those over 80 yrs old. Low-Do…

AM

arun achuthan/dr/mr

@arun4513 · X

Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation | NEJM https://t.co/uSSxDCazSr